Haoxi Health Technology Ltd
Data quality: 100%
HAO
Nasdaq
Services
Business Services
$1.11
▲
$0.05
(4.72%)
Mkt Cap: 65.98 M
Price
$1.11
Mkt Cap
65.98 M
Day Range
$1.07 — $1.12
52-Week Range
$0.82 — $2.31
Volume
1,791
Open $1.09
50D / 200D Avg
$1.21
8.39% below
50D / 200D Avg
$1.20
7.13% below
Quick Summary
Key Takeaways
Earnings grew 200.13% over the past year
ROE of 27.06% indicates high profitability
Debt/Equity of 0.08 — conservative balance sheet
Negative free cash flow of -3.41 M
Capital efficient — spends only 0.17% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-32.39%
Earnings (1Y)200.13%
FCF Growth (3Y)N/A
Quality
Return on Equity
27.06%
Above sector avg (-15.95%)
ROIC-11.87%
Net Margin11.82%
Op. Margin-6.10%
Safety
Debt / Equity
0.08
Below sector avg (0.39)
Current Ratio6.02
Interest Coverage-43.52
Valuation
PE (TTM)
17.02
Above sector avg (-1.17)
P/B Ratio3.52
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (502 peers)
Peer Comparison
vs Services sector median (502 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 17.0 | -1.2 |
| P/B | 3.5 | 1.4 |
| ROE % | 27.1 | -16.0 |
| Net Margin % | 11.8 | -19.4 |
| Rev Growth 5Y % | — | 4.0 |
| D/E | 0.1 | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -32.39% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | 200.13% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 32.80 M | Net Income (TTM) | 3.88 M |
| ROE | 27.06% | ROA | 20.90% |
| Gross Margin | 2.83% | Operating Margin | -6.10% |
| Net Margin | 11.82% | Free Cash Flow (TTM) | -3.41 M |
| ROIC | -11.87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.08 | Current Ratio | 6.02 |
| Interest Coverage | -43.52 | Asset Turnover | 1.77 |
| Working Capital | 16.53 M | Tangible Book Value | 16.73 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 17.02 | Forward P/E | N/A |
| P/B Ratio | 3.52 | P/S Ratio | 2.01 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5.17% | ||
| Market Cap | 65.98 M | Enterprise Value | 67.41 M |
| Per Share | |||
| EPS (Diluted TTM) | 1.32 | Revenue / Share | 0.55 |
| FCF / Share | -0.06 | OCF / Share | -0.06 |
| EPS CAGR (1Y) | 3200.00% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.17% | FCF Conversion | -88.05% |
| SBC-Adj. FCF | -3.47 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 32.80 M | 48.52 M |
| Net Income | 3.88 M | 1.29 M |
| EPS (Diluted) | 1.32 | 0.04 |
| Gross Profit | 927,750.0 | 2.75 M |
| Operating Income | -2.00 M | 1.72 M |
| EBITDA | — | — |
| R&D Expenses | 79,544.0 | 79,985.0 |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | 45,956.0 | 41,186.0 |
| Income Tax | 270,744.0 | 443,582.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 21.60 M | 15.51 M |
| Total Liabilities | 4.22 M | 4.23 M |
| Shareholders' Equity | 17.38 M | 11.27 M |
| Total Debt | 1.61 M | 1.14 M |
| Cash & Equivalents | — | 6.66 M |
| Current Assets | 19.60 M | 15.38 M |
| Current Liabilities | 3.89 M | 3.87 M |
{"event":"ticker_viewed","properties":{"ticker":"HAO","listing_kind":"stock","pathname":"/stocks/hao","exchange":"Nasdaq","country":"US"}}